Up a level |
(2022) Exosome as a target for cancer treatment. Journal of Investigative Medicine.
(2021) Genetically modified bone marrow mesenchymal stem cells and dental pulp mesenchymal stem cells by HIF-1alpha overexpression, differs in survival and angiogenic effects after in animal model of hind limb ischemia. Gene Reports. p. 9.